[Three years of experience in the polychemotherapy of inoperable bronchial carcinoma].
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D002282:Adenocarcinoma, Bronchiolo-Alveolar / Q000188:drug therapy* / Q000401:mortality; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001317:Austria; D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D010166:Palliative Care; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014747:Vinblastine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Erfahrungen über 3 Jahre Polychemotherapie bei inoperablen Bronchuskarzinomen